Tag: Dovato

Dovato (dolutegravir/lamivudine) is a complete, two-drug regimen in a single tablet for treating HIV-1 infection [1.5.5, 1.5.6]. To ensure its effectiveness and avoid harmful effects, it is crucial to understand what to avoid when taking Dovato.

First approved in 2006, Atripla was a revolutionary single-tablet regimen for HIV treatment, dramatically simplifying therapy for many patients. However, with over 15 years of new drug development in pharmacology since its introduction, a key question for many people with HIV is: is Atripla still recommended?.